Bethesda, MD, United States of America

Gillian Einstein

This inventor holds 1 USPTO granted patent. Top assignee: Duke University. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gillian Einstein. Retrieved from https://idiyas.com/inventor/gillian-einstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Biography of Inventor Gillian Einstein

Introduction: Gillian Einstein is a notable inventor based in Bethesda, MD (US). She has made significant contributions to the field of Alzheimer's disease research, particularly through her innovative patent.

Latest Patents: Gillian Einstein holds a patent for a method of determining Alzheimer's disease risk using apolipoprotein E4 genotype analysis in combination with decreased estrogen levels. This method involves screening a subject for the presence of at least one ApoE4 allele and assessing estrogen levels, which can indicate a greater risk of developing Alzheimer's disease.

Career Highlights: Gillian Einstein is affiliated with Duke University, where she continues her research and development in the field of neurodegenerative diseases. Her work has the potential to improve screening and treatment options for individuals at risk of Alzheimer's disease.

Collaborations: Throughout her career, Gillian has collaborated with esteemed colleagues, including Laura W Shaughnessy and Donald E Schmechel. These collaborations have furthered her research and contributed to advancements in understanding Alzheimer's disease.

Conclusion: Gillian Einstein's innovative work and dedication to Alzheimer's research exemplify her commitment to improving health outcomes for individuals at risk of this debilitating disease. Her contributions are invaluable to the scientific community and the patients they serve.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…